A new study says that a drug that dissolves blood clots in the brain can benefit patients up to 4.5 hours after a stroke.
Till date, the useful limit for administering thrombolytic drugs was believed to be just three hours.
Stroke
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
Advertisement
"These new insights will benefit tens of thousands of patients whose cerebral circulation could be restored," said the study director, Professor Dr. Werner Hacke, Medical Director of the Neurology Clinic at Heidelberg University Hospital.
In the study, 826 patients in 130 European stroke centres who were treated in the clinic between 3 and 4.5 hours after a stroke were injected with either the thrombolytic drug alteplase or a placebo.
![Diet and High Blood Pressure]( "Diet and High Blood Pressure")
High blood pressure or hypertension is defined as a blood pressure of above 140 mm Hg (systolic) and or 90mm Hg (diastolic).
Initially, CT scan ruled out Cerebral haemorrhage as a cause of the stroke.
Almost 52 percent of the patients treated with alteplase responded well to treatment and suffered no or only slight impairment, while in the placebo group, there were only 45 percent responders. The mortality rate was very low and identical in both groups (8 percent).
Thus, researcher suggested that stroke patients could be treated with thrombolytic drugs even after three hours.
"But having more time does not mean that we can take more time", warned Professor Hacke.
He added that patients with signs of a stroke should still be brought to the hospital and treated as soon as possible. Previous analyses clearly showed that patients respond best the earlier they received treatment.
Also, the study will set an important course - there had been no positive study on acute stroke therapy for more than 12 years, and ECASS 3 is just the second acute study ever to have a positive result for strokes.
"This study will have an impact on the entire field of stroke treat-ment. It has finally been demonstrated again that stroke can be treated and this will encourage many researchers and companies to continue to work in this field," said Professor Hacke.
The results of the study, namely "European Cooperative Acute Stroke Study 3" (ECASS 3) have now been published in the "New England Journal of Medicine".
Source: ANI
RAS/L
Diet and High Blood Pressure
High blood pressure or hypertension is defined as a blood pressure of above 140 mm Hg (systolic) and or 90mm Hg (diastolic).
Advertisement
Initially, CT scan ruled out Cerebral haemorrhage as a cause of the stroke.
Almost 52 percent of the patients treated with alteplase responded well to treatment and suffered no or only slight impairment, while in the placebo group, there were only 45 percent responders. The mortality rate was very low and identical in both groups (8 percent).
Thus, researcher suggested that stroke patients could be treated with thrombolytic drugs even after three hours.
"But having more time does not mean that we can take more time", warned Professor Hacke.
He added that patients with signs of a stroke should still be brought to the hospital and treated as soon as possible. Previous analyses clearly showed that patients respond best the earlier they received treatment.
Also, the study will set an important course - there had been no positive study on acute stroke therapy for more than 12 years, and ECASS 3 is just the second acute study ever to have a positive result for strokes.
"This study will have an impact on the entire field of stroke treat-ment. It has finally been demonstrated again that stroke can be treated and this will encourage many researchers and companies to continue to work in this field," said Professor Hacke.
The results of the study, namely "European Cooperative Acute Stroke Study 3" (ECASS 3) have now been published in the "New England Journal of Medicine".
Source: ANI
RAS/L
Blood Thinning Drug Linked to Increased Risk of Bleeding in Brain
People who take the commonly used blood thinning drug warfarin may have larger amounts of bleeding in the brain and increased risk of death if they suffer a hemorrhagic stroke, according
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.